Scheriproct Ointment 5Mg-1.9Mg 30G 1

Description

1. What Scheriproct is and what it is used for?

Scheriproct contains a substance which reduces inflammation (prednisolone) and a local anaesthetic (cinchocaine) which relieves pain.

This medicine is used for the relief of the inflammation, swelling, itching and soreness of piles (haemorrhoids) and to relieve itching of the anus (back passage). It is used short-term usually for 5 to 7 days.

2. What you need to know before you use Scheriproct

Do not use Scheriproct:  if you are allergic to prednisolone hexanoate, cinchocaine hydrochloride, other local anaesthetics or any of the other ingredients of this medicine (listed in section 6).  if you have a viral infection (e.g. herpes, shingles, chicken-pox)  if you have any bacterial or fungal infections of the skin or elsewhere for which you are not receiving treatment.

Warnings and precautions :

Talk to your doctor or pharmacist before using Scheriproct  Long-term continuous treatment should be avoided because it increases the possibility of side effects. This is particularly important for infants and small children because continuous treatment with Scheriproct for long periods may reduce the activity of the adrenal glands and so lower resistance to disease. Also, long-term treatment can cause the skin to thin and deteriorate in the affected area (see section 4) and some of the medicine may be absorbed into the blood stream.  If the area treated with Scheriproct is also infected your doctor should prescribe another medicine, to use with Scheriproct, to treat the infection.  Do not use a waterproof dressing to cover areas where you have applied the cream.  In case latex products such as condoms are used concomitantly in the area of treatment with Scheriproct its ingredient(s) may cause damage to those latex products. Therefore, these may no longer be effective as contraception or as protection against sexually transmitted diseases such as HIV infection. Talk to your doctor or pharmacist, if you require more information.